Skip to content

Clinical trials

Phase 4 Premature Birth trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Premature Birth Phase: Phase 4 Clear all

117 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20023
20032
20043
20053
20065
20077
20082
20094
20105
20116
20125
20134
20144
20155
20165
20177
20186
20195
20204
20216
20223
20237
20244
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70
Unknown status19
Terminated11
Recruiting10
Not yet recruiting3
Withdrawn3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zekai Tahir Burak Women's Health Research and Education Hospital5
Ain Shams University3
Thomas Jefferson University3
Alexandria University2
Assistance Publique - Hôpitaux de Paris2
Christiana Care Health Services2
Duke University2
European Institute for Evidence Based Osteopathic Medicine2
Maternal-Infantil Vall d´Hebron Hospital2
Maternite Regionale Universitaire2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Premature Birth117
Obstetric Labor, Premature8
Respiratory Distress Syndrome8
Ductus Arteriosus, Patent7
Hyperphagia5
Apnea4
Bronchopulmonary Dysplasia4
Respiratory Distress Syndrome, Newborn4
Fetal Growth Retardation3
Perinatal Death3

Trials

Showing 51 to 75 of 117. Each trial links to its page on Pharma Observatory.

17 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.